SG Americas Securities LLC lifted its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 25.8% in the 4th ...
The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.
Among patients with iRBD, altered visuospatial cue-elicited N2 and P3 ERPs predicted phenoconversion to α-synucleinopathies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback